| Ipca Laboratories has reported a sales turnover of Rs 466.36 crore and a net profit of Rs 63.95 crore for the quarter ended Dec '10. | | For the quarter ended Dec 2009 the sales turnover was Rs 395.70 crore and net profit was Rs 58.25 crore. |
|
| | Quarterly Results of Ipca Laboratories | -------- in Rs. Cr. -------- |
|
| Dec '09 | | | Sep '10 | Dec '10 | | Sales Turnover | 395.70 | | | 518.29 | 466.36 | | Other Income | 0.91 | | | 0.75 | 0.35 | | Total Income | 396.61 | | | 519.04 | 466.71 | | Total Expenses | 305.39 | | | 400.29 | 375.37 | | Operating Profit | 90.31 | | | 118.00 | 90.99 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -1.65 | | | 28.84 | 11.21 | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 91.22 | | | 118.75 | 91.34 | | Interest | 5.29 | | | 6.20 | 5.61 | | PBDT | 84.28 | | | 141.39 | 96.94 | | Depreciation | 11.93 | | | 13.68 | 14.19 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 72.35 | | | 127.71 | 82.75 | | Tax | 14.10 | | | 33.70 | 18.80 | | Net Profit | 58.25 | | | 94.01 | 63.95 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 23.27 | | | 7.51 | 5.09 | | Book Value | -- | | | -- | -- | | Equity | 25.03 | | | 25.04 | 25.12 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 2.00 | 2.00 | | Source : Religare Technova |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
